pyridoxal phosphate has been researched along with phenylephrine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kapoor, JR; Sladek, CD | 1 |
| Buckwalter, JB; Clifford, PS; Hamann, JJ; Taylor, JC | 1 |
| Buckwalter, JB; Clifford, PS; Hamann, JJ; Kluess, HA | 1 |
| Bardhan, KD; Brookes, SJ; Brunsden, AM; Grundy, D | 1 |
| Burnstock, G; Gur, S; Hellstrom, WJ; Knight, GE; Sikka, SC | 1 |
6 other study(ies) available for pyridoxal phosphate and phenylephrine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release.
Topics: Adenosine Triphosphate; Adrenergic Agonists; Adrenergic alpha-1 Receptor Agonists; Animals; Culture Techniques; Drug Synergism; Enzyme Inhibitors; Hypothalamo-Hypophyseal System; Indoles; Male; Maleimides; Norepinephrine; Nucleic Acid Synthesis Inhibitors; Oxytocin; Phenylephrine; Protein Kinase C; Purinergic Agonists; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Vasopressins | 2000 |
Do P2X purinergic receptors regulate skeletal muscle blood flow during exercise?
Topics: Adenosine Triphosphate; Animals; Dogs; Extremities; Functional Laterality; Muscle, Skeletal; Phenylephrine; Physical Exertion; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X; Regional Blood Flow | 2004 |
Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries.
Topics: Acidosis; Adenosine Triphosphate; Animals; Arteries; Hydrogen-Ion Concentration; Male; Muscle, Skeletal; Phenylephrine; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Vasoconstriction | 2005 |
Mechanisms underlying mechanosensitivity of mesenteric afferent fibers to vascular flow.
Topics: Action Potentials; Androstadienes; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; In Vitro Techniques; Ion Channels; Male; Mechanotransduction, Cellular; Mesentery; Myosin-Light-Chain Kinase; Neurons, Afferent; omega-Conotoxins; Phenylephrine; Protein Kinase Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Purinergic P2; Ruthenium Red; Splanchnic Circulation; Time Factors; Vasoconstrictor Agents; Wortmannin | 2007 |
Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil.
Topics: Adenosine Triphosphate; Animals; Electric Stimulation; Enzyme Inhibitors; Hypertension; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Phenylephrine; Piperazines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Purines; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X3; Sildenafil Citrate; Sulfones; Vas Deferens; Vasodilator Agents | 2010 |